Company Overview and News

 
A Purchase By Lonestar Resources Turns Around The Company

2018-08-26 seekingalpha
One purchase of leases in bankruptcy proceeding has made a big difference in the production outlook.
CRC LNR

153
Stocks To Watch: Alibaba, Target And Energy Plays To Center Stage

2018-08-18 seekingalpha - 3
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
FOCS PDD LGCYP LGCYO QEP TJX EL AVGO ABBV FTNT KLXI CORR ESES SDPI TENB LNR RRS WPX FSBW ESTE NPTN ERF BABA SDCJF PAY MSFT GPS MPOYQ HRS FL MLM BLCN MOS SEA CLPS LB CLB ROSEU DBX CF CRDAF KSS CRDAD CI SSI JAG ROSE SNDE DAVA SJM UNT HUM EOG BHI RGRYY MU LGCY SBUX MNK WRD LOW JKS TOL LONE ERF CLB FTK AMAT CRD KEG KEGX SOXX STT FSWB WLL AQST SM LBRT BV LLEX ADIL NBR RGRLF CMG RRC INTU HIMX BJRI EDUC BE MPO ABBV BA ESRX ECR JG NDLS WPXP MTB RRL VMW ALRM LQDA RMBS ECA CANG ICD OPRA IBM WISA CDEV JGPK LYB COG ECA SPDI SBOW PHX TGT NTR BRY HPQ URBN TELL

4
Penn Virginia: Potential Stock Upside On Strong Production Growth, High Price Realization And Deleveraging

2018-08-13 seekingalpha
Strong production growth to sustain in 2H18 and FY19. With higher realized oil prices, there is robust EBITDAX growth visibility.
PVAC PVAYQ PVA LNR

 
Lonestar Resources: More Juice In The Rally As Strong Production Growth To Sustain

2018-08-09 seekingalpha
Strong production growth is likely to sustain for the company in the next 12-18 months and this will support healthy growth in EBITDAX and cash flows.
LNR

 
Lonestar Resources US Inc. (LONE) CEO Frank Bracken on Q2 2018 Results - Earnings Call Transcript

2018-08-06 seekingalpha
Lonestar Resources US Inc. (NASDAQ:LONE) Q2 2018 Results Earnings Conference Call August 6, 2018 10:00 AM ET
LONE LNR

30
Sanchez Energy Profit Progress

2018-07-15 seekingalpha - 1
A large $2.3 billion acquisition like Comanche often takes a few years to optimize results. The previous large acquisition, Catarina, took a few years.
SN APC CKRGZ CHKVP BGFLX SCAZP LNR CHKDH CHKVZ CHKDG EOG CHKWZ CHKDJ CHKDP CHK.WI CHK SNZYP AEUA

63
Penn Virginia (PVAC) Hits Fresh High: Is There Still Room to Run?

2018-06-27 zacks - 1
Have you been paying attention to shares of Penn Virginia (PVAC - Free Report) ? Shares have been on the move with the stock up 35.3% over the past month. PVAC hit a new 52-week high of $85.96 in the previous session. Penn Virginia has gained 114.5% since the start of the year compared to the 2.9% move for the Oils-Energy sector and the 3% year-to-date return for its peer group.
APC CQP WLL LNG PVAC PVAYQ PVA LNR AEUA

17
Stoneridge (SRI) Soars to 52-Week High, Time to Cash Out?

2018-06-27 zacks - 1
Have you been paying attention to shares of Stoneridge (SRI - Free Report) ? Shares have been on the move with the stock up 18% over the past month. SRI hit a new 52-week high of $37.20 in the previous session. Stoneridge has gained 60.9% since the start of the year compared to the 5.7% move for the Computer and Technology sector and the -5.6% year-to-date return for its peer group.
VPG.WI PVAC PVAYQ TEL PVA SRI LNR NOVT VPG

62
Penn Virginia (PVAC) Hits Fresh High: Is There Still Room to Run?

2018-06-26 zacks
Have you been paying attention to shares of Penn Virginia (PVAC - Free Report) ? Shares have been on the move with the stock up 35.3% over the past month. PVAC hit a new 52-week high of $85.96 in the previous session. Penn Virginia has gained 114.5% since the start of the year compared to the 2.9% move for the Oils-Energy sector and the 3% year-to-date return for its peer group.
APC CQP WLL LNG PVAC PVAYQ PVA LNR AEUA

28
Stoneridge (SRI) Hits Fresh High: Is There Still Room to Run?

2018-06-26 zacks
Have you been paying attention to shares of Stoneridge (SRI - Free Report) ? Shares have been on the move with the stock up 18% over the past month. SRI hit a new 52-week high of $37.20 in the previous session. Stoneridge has gained 60.9% since the start of the year compared to the 5.7% move for the Computer and Technology sector and the -5.6% year-to-date return for its peer group.
VPG.WI WLL PVAC PVAYQ TEL PVA SRI LNR NOVT VPG

72
Whiting Petroleum (WLL) Hits 52-Week High, Can the Run Continue?

2018-06-25 zacks
Have you been paying attention to shares of Whiting Petroleum (WLL - Free Report) ? Shares have been on the move with the stock up 9.7% over the past month. WLL hit a new 52-week high of $56.47 in the previous session. Whiting Petroleum has gained 109.4% since the start of the year compared to the 5.2% move for the Oils-Energy sector and the 5.4% year-to-date return for its peer group.
APC LOPE CQP WLL LNG HFC CTLR NYTAB CLR LNR AEUA

15
WellCare Health (WCG) Hits Fresh Highs: Is There Still Room to Run?

2018-06-25 zacks
Have you been paying attention to shares of WellCare Health Plans (WCG - Free Report) ? Shares have been on the move with the stock up 12.1% over the past month. WCG hit a new 52-week high of $244.69 in the previous session. WellCare Health Plans has gained 21.4% since the start of the year compared to the 2.1% move for the Medical sector and the 14.3% year-to-date return for its peer group.
LOPE WLL HFC WCG NYTAB LNR

74
Lonestar Resources (LONE) Soars to a 52-Week High, Time to Cash Out?

2018-06-25 zacks
Have you been paying attention to shares of Lonestar Resources US (LONE - Free Report) ? Shares have been on the move with the stock up 24.8% over the past month. LONE hit a new 52-week high of $8.90 in the previous session. Lonestar Resources has gained 115.4% since the start of the year compared to the 5.2% move for the Oils-Energy sector and the 5.4% year-to-date return for its peer group.
APC LOPE CQP WLL LNG LONE HFC CTLR NYTAB CLR LNR AEUA

20
Lonestar Resources: Improving Credit Metrics And Stellar Production Growth To Drive Upside

2018-06-05 seekingalpha
Lonestar Resources expects 64% production growth in FY18 and the growth visibility for FY19 also looks attractive. This is translating into an EBITDA bump-up and stock upside.
RRC RGRYY PVAC PVAYQ PVA RRL LNR RRS RGRLF

39
5 Top Energy Stocks to Buy Right Now

2018-05-23 zacks
Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.
APC CVX WRD UTX LNR AEUA

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...